ClinSpec Dx progress to phase three of Converge Challenge

ClinSpec Dx are through to the third phase of the Converge Challenge. Watch Matt Baker talk about our technology here .

Recent Posts

Dr Paul Brennan joins the Dxcover Scientific Advisory Board

Dxcover® are delighted to announce the appointment of Dr Paul Brennan to their Scientific Advisory Board (SAB). Dr Brennan is a Reader and Consultant Neurosurgeon at the University of Edinburgh and NH

Early brain cancer detection breakthrough for Dxcover

· Blood test proves ability to identify really small brain tumours and gives hope of earlier detection and improved survival · Dxcover acquires all IP for its Dxcover® Liquid Biopsy Technology and Mul

The future of cancer diagnostics is now

We were delighted to speak to Health Tech World recently about the future of cancer diagnostics. “Hailed as the future of cancer diagnostics, Dxcover is set to revolutionise healthcare by pioneering a